|
|
||||||||
RESEARCH AND PRACTICE |
Kevin Fiscella, Naomi Pless, and Sean Meldrum are with the Department of Family Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY. Kevin Fiscella is also with the Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry. Paul Fiscella is in private law practice in Hampton, Va.
Correspondence: Requests for reprints should be sent to Kevin Fiscella, MD, MPH, Family Medicine Center, 885 South Ave, Rochester, NY 14620-2399 (e-mail: kevin_fiscella{at}urmc.rochester.edu).
| ABSTRACT |
|---|
|
|
|---|
We sought to estimate the number of arrestees at risk for inadequately treated drug and alcohol withdrawal in US jails. We used Arrestee Drug Abuse Monitoring Program data to estimate prevalence rates of alcohol and opiate dependence. Our results revealed rates of alcohol and opiate dependency among arrestees of approximately 12% and 4%, respectively; only 28% of jail administrators reported that their institutions had ever detoxified arrestees. Inadequately treated drug and alcohol withdrawal in US jails appears widespread. Our data raise important ethical and constitutional questions.
| INTRODUCTION |
|---|
|
|
|---|
| METHODS |
|---|
|
|
|---|
| RESULTS |
|---|
|
|
|---|
|
Estimates of Untreated Alcohol and Opiate Withdrawal
Only 28% of jail administrators reported that their jails provided alcohol or drug detoxification services. Among administrators reporting that their institutions had never provided such services, only 10% indicated that detoxification or drug treatment had been provided off-site.9 Smaller jails were less likely than larger jails to offer detoxification. After weighting of jail size estimates, results showed that 63% of all arrestees were detained in facilities reported as never detoxifying inmates. Thus, we estimate that roughly 756 000 (1 200 000 x 0.63) arrestees are at risk for untreated alcohol withdrawal, and 277 000 (440 000 x 0.63) are at risk for untreated opiate withdrawal.
| DISCUSSION |
|---|
|
|
|---|
The present findings have implications for human rights, particularly in the case of members of minority groups, who are arrested at disproportionately high rates.20 Withdrawal symptoms often begin before arrestees have been formally charged with a crime (which may take up to 72 hours21). Thus, arrest and detention may result in pain, suffering, and morbidity among alcohol- or opiate-dependent individuals who have not yet been charged with, much less convicted of, a crime. The implicit threat of withdrawal after detention may coerce arrestees into providing information they might not otherwise volunteer.22
There are several caveats to our findings. First, national rates of dependence are based on extrapolations from ADAM data, which are compiled at the community level; weights necessary to generate reliable national estimates have not yet been developed. Second, self-reported dependency is a relatively crude measure of physiological dependence. Data on rates of severe withdrawal among arrestees are not available.
Third, the data we compiled regarding availability of detoxification in jails were based on responses to a single question. Conceivably, jail administrators may have misconstrued the question or been unaware of detoxification services provided in their institutions. However, research has shown that only 1% of inmates who admit abusing drugs or alcohol at the time of their arrest report receiving detoxification in jail.23 Finally, we did not match community-specific rates of alcohol or opiate dependency with rates of detoxification availability. It is plausible that jails with higher rates of dependency are more likely to provide detoxification.
In conclusion, the data obtained in this study suggest that inadequately treated alcohol and opiate withdrawal are widespread in US jails. Although more reliable data are needed, our results suggest the need for national, enforceable standards in regard to alcohol and opiate detoxification in US jails.
| Acknowledgments |
|---|
Human Participant Protection
No protocol approval was needed for this study.
| Footnotes |
|---|
Accepted for publication May 5, 2003.
| References |
|---|
|
|
|---|
2. Lancaster v Monroe County, Alabama, 116 F3d 1419 (11th Cir 1997).
3. New York State Commission of Corrections. A death in Madison County. Available at: http://www.sic.state.ny.us/publication/Investigations/96-1.html. Accessed July 27, 2001.
4. Peterson v Traill County, 601 NW2d 268 (ND 1999).
5. American Civil Liberties Union of Colorado. ACLU sues El Paso county jail over death of inmate. Available at: http://www.aclu-co.org/news/pressrelease/release_spillane.htm. Accessed July 27, 2001.
6. Kocks J. Coroner: Wichita County jail inmate died of alcohol withdrawal. Times Record News. July 26, 2001:A1.
7. Thompson v Upshur County, Texas, 245 F3d 447 (5th Cir 2001).
8. Flanigan P. State hits Monroe in death of inmate. Democrat & Chronicle. March 30, 2001:A1, A7.
9. Substance Abuse Treatment in Adult and Juvenile Correctional Facilities: Findings From the Uniform Facilities Data Set 1997 Survey of Correctional Facilities. Rockville, Md: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2000.
10. Arrestee Drug Abuse Monitoring Program: Adult Program Findings, 1997. Washington, DC: National Institute of Justice; 1997.
11. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92:17891994.
12. Department of Justice, Federal Bureau of Investigation. Uniform crime reports for the United States, 1997. Available at: http://www.fbi.gov/ucr/Cius_97/97crime/97crime.pdf. Accessed November 9, 2002.
13. Young L. Improving quality and oversight of methadone treatment. Available at: http://www.samhsa.gov/press/99/990722fs.htm. Accessed August 10, 2001.
14. Appel PW, Joseph H, Kott A, Nottingham W, Tasiny E, Habel E. Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State. Mt Sinai J Med. 2001;68:5561.[Medline]
15. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278:144151.[Abstract]
16. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am J Psychiatry. 1995;152(suppl):159.[ISI]
17. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280:19361943.
18. Standards for Health Services in Jails. Chicago, Ill: National Commission on Correctional Health Care; 1996.
19. Federal Bureau of Prisons. Clinical Practice Guidelines: Detoxification of Chemically Dependent Persons. Washington, DC: National Institute of Corrections; 2000:144.
20. Wolf Harlow C. Profile of Jail Inmates 1996. Washington, DC: Bureau of Justice Statistics; 1998.
21. Perkins CA, Stephan JJ, Beck AJ. Jails and Jail Inmates 199394: Census of Jails and Survey of Jails. Washington, DC: US Dept of Justice; 1995.
22. Goldfarb R. Jails: The Ultimate Ghetto. Garden City, NY: Doubleday; 1975.
23. Wilson DJ. Drug Use, Testing, and Treatment in Jails. Washington, DC: Bureau of Justice Statistics; 2000.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |